What Researchers Did
This study investigated the effect of hyperbaric oxygen therapy (HBOT) as a complementary treatment on diabetic foot ulcer (DFU) healing by measuring VEGF and TNF-α levels in 32 diabetic patients.
What They Found
After four weeks, the HBOT group showed significantly elevated VEGF levels (p = 0.013) and decreased TNF-α levels (p = 0.01) compared to the control group. Faster epithelialization was observed in the HBOT group (p < 0.001), with HBOT directly affecting epithelialization (p < 0.001) and indirectly through VEGF levels (p = 0.042).
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers might benefit from hyperbaric oxygen therapy as a complementary treatment to accelerate wound healing. This therapy could potentially improve epithelialization by modulating inflammatory and growth factors.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's relatively small sample size and short duration may limit the generalizability of the findings.